Mahalingam, D., Harb, W., Patnaik, A., Ulahannan, S., Mahdi, H., Ahluwalia, M., Patel, M., Dowlati, A., Bullock, A., Wen, P., Pant, S., Mulcahy, M., Guttendorf, R., Vaickus, L., Wang, S., Crochiere, M., Vincent, M., Cieslewicz, M., & Watnick, J. (n.d.). 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. Journal for immunotherapy of cancer, 8, A228. http://access.bl.uk/ark:/81055/vdc_100144728297.0x000003